Annual report pursuant to Section 13 and 15(d)

Acquisition of Curedm (Tables)

v3.20.1
Acquisition of Curedm (Tables)
12 Months Ended
Dec. 31, 2019
Acquisition Of Curedm [Abstract]  
Schedule of consideration

25,000,000 shares of the Company's common stock   $ 1,250,000  
22,741,140 contingency shares of the Company's common stock      
         
Total consideration   $ 1,250,000  
Schedule of fair value of assets acquired and liabilities assumed

Assets acquired:      
Cash   $ 3,592  
Property and equipment     273  
Goodwill     1,176,220  
Intangibles     234,122  
Liabilities assumed:        
Accounts payable and accrued expenses     (164,207 )
Net assets acquired   $ 1,250,000  
Schedule of pro forma results

    For the year ended
December 31,
 
    2019     2018  
Total revenues   $ 16,329     $ 31,273  
Net loss     (2,371,177 )     (3,601,217 )
Basic and diluted net earnings per common share   $ (0.02 )   $ (0.04 )